Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 199 of 5804
-
Could a pill supercharge brain stimulation for depression?
Disease control Not yet recruitingMajor depressive disorder (MDD) is a significant public health problem and leading cause of worldwide disability. Treatment resistance is common in MDD, however, for these individuals, targeted noninvasive brain stimulation is an alternative. Repetitive transcranial magnetic stim…
Phase: PHASE2, PHASE3 • Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a drug for rare blood disorder help pregnant women with severe preeclampsia?
Disease control Recruiting nowThe researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New injection combo takes aim at tough skin cancers
Disease control Recruiting nowOpen-label, single-arm, multicenter study in patients with locally advanced, histologically confirmed Cutaneous Squamous Cell Carcinoma (LacSCC) amenable to intratumoral injection, who have progressed on or are intolerant to Immune Checkpoint Inhibitor (ICI). The primary objectiv…
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for HIV patients: cheaper chemo may work just as well for kaposi sarcoma
Disease control Not yet recruitingThis study is being done to determine if two different anti-cancer drugs, paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) have similar effects on treating Kaposi Sarcoma (KS) in people living with HIV (human immunodeficiency virus) in sub-Saharan Africa. Patients with …
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Not yet recruitingThis study is designed to evaluate the efficacy, safety, and mechanisms of pulsENDO procedure in patients with T2DM and its effect on MASLD.
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could your own stem cells fight this rare brain disorder?
Disease control Not yet recruitingThis study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate funct…
Phase: PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New light treatment could fight oral cancer without surgery
Disease control Not yet recruitingThe primary goal of this study is to see if photodynamic therapy (PDT) is effective for treatment of lesions in the oral cavity which have high risk of becoming oral cancer. PDT treatment uses a drug, called a photosensitizer, which makes the diseased cells become light-sensitive…
Phase: PHASE2 • Sponsor: University of Massachusetts, Boston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Blood test may let some stomach cancer patients skip harsh chemo
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to assess if circulating tumor DNA, as assessed by Signatera tumor-informed MRD assay, can guide de-escalation of adjuvant therapy in patients with resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer. The main question it aims to answer is…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New targeted pill aims to keep KRAS lung cancer from returning after surgery
Disease control Not yet recruitingThe main purpose of this study is to evaluate the efficacy of divarasib compared with investigator's choice of immunotherapy (pembrolizumab or nivolumab) or observation in participants with resected Kirsten rat sarcoma viral oncogene homolog glycine 12 to cysteine (KRAS G12C)-pos…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Massive 30,000-Patient trial launches to test new heart rhythm fix
Disease control Not yet recruitingPOTENTIAL-AF is a prospective, multicentre, observational registry study evaluating the real-world effectiveness and safety of bi-polar pulse-field tip-catheter ablation (PFA) for atrial fibrillation (AF) in China. The study will enrol 30,000 adult patients with symptomatic parox…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for hard-to-treat prostate cancer: drug combo trial launches
Disease control Not yet recruitingThis study will first conduct a phase II clinical study, and on the basis of the phase II clinical study, subsequent clinical research will be carried out.
Phase: PHASE2, PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Rolling hospital room: could a mobile diagnostic unit slash nursing home hospitalisations?
Disease control Not yet recruitingThis prospective observational before-after study evaluates the impact of a Mobile Geriatric Unit (MGU) on hospitalisation rates among nursing home residents. The study includes a 12-month control phase with usual care followed by a 12-month intervention phase during which the MG…
Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a popular Weight-Loss drug help—or Harm—Those with duchenne muscular dystrophy?
Disease control Not yet recruitingDuchenne Muscular Dystrophy (DMD) is a rare, genetic disease that leads to muscle weakness, breathing difficulties, heart disease, and early death. Approximately half of individuals with DMD have elevated body mass indices (BMIs) in the overweight or obesity range. High BMI is du…
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a pill replace CPAP for sleep apnea? large study tests three treatments Head-to-Head
Disease control Not yet recruitingResearchers want to identify which treatments for obstructive sleep apnea (OSA) work best and are easiest for patients to use consistently. Eligible participants will be randomly assigned one of three OSA treatments: traditional PAP therapy, a dental device, or a combination of t…
Phase: PHASE4 • Sponsor: Sairam Parthasarathy • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
Disease control Not yet recruitingThis is a national multicenter, prospective, randomized controlled trial. The study aims to compare the 5-year overall survival (OS) between patients receiving primary tumor surgery followed by systemic therapy (surgery group) and those receiving systemic therapy alone (non-surge…
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Custom-Made vaccine aims to boost immune attack on kidney tumors
Disease control Not yet recruitingThis is a Phase I, single-center, open-label, single-arm clinical trial to evaluate the safety and efficacy of personalized neoantigen polyepitope peptide vaccine combined with pembrolizumab in patients with advanced, recurrent or refractory renal cell carcinoma (RCC). Backgroun…
Phase: PHASE1 • Sponsor: Jian Lin • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could microplastics sabotage cancer treatment? new study investigates
Knowledge-focused Not yet recruitingMICRORAD is a pioneering 48-month translational research project that investigates the potential health and environmental impacts of micro- and nanoplastics (MNPs) released from medical devices when exposed to ionizing radiation. In radiation oncology, thermoplastic masks (TPMs) …
Sponsor: University of Kragujevac • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Zapping a nerve inside the spine bone may ease chronic back pain
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether the Spinery® RF Generator and its sterile single-use accessories can safely lower disability and pain in adults with long-term low back pain that is thought to come from changes inside the vertebral bones of the lower spine. Thi…
Phase: NA • Sponsor: Axon srl • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers with KRAS mutation
Disease control Not yet recruitingThis is a first-in-human (FIH), multicenter, open-label, phase I study of ABSK211 in participants with advanced solid tumors to evaluate safety, tolerability, PK and optimize the dosage.
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
Knowledge-focused Not yet recruitingInflammatory lung diseases, including chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), are major causes of morbidity and mortality worldwide. Their development and progression are influenced by environmental exposures, such as cigarette smokin…
Phase: NA • Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC